DK0735863T3 - Præparat indeholdende bromocriptin med accelereret frigørelse - Google Patents
Præparat indeholdende bromocriptin med accelereret frigørelseInfo
- Publication number
- DK0735863T3 DK0735863T3 DK95906146T DK95906146T DK0735863T3 DK 0735863 T3 DK0735863 T3 DK 0735863T3 DK 95906146 T DK95906146 T DK 95906146T DK 95906146 T DK95906146 T DK 95906146T DK 0735863 T3 DK0735863 T3 DK 0735863T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation containing
- accelerated release
- bromocriptine
- containing bromocriptine
- dosage form
- Prior art date
Links
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 title abstract 2
- 229960002802 bromocriptine Drugs 0.000 title abstract 2
- 239000006186 oral dosage form Substances 0.000 abstract 2
- 102000003946 Prolactin Human genes 0.000 abstract 1
- 108010057464 Prolactin Proteins 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940097325 prolactin Drugs 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Developing Agents For Electrophotography (AREA)
- Pens And Brushes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17189793A | 1993-12-22 | 1993-12-22 | |
PCT/US1994/014994 WO1995017170A1 (en) | 1993-12-22 | 1994-12-22 | Accelerated release composition containing bromocriptine |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0735863T3 true DK0735863T3 (da) | 2002-12-16 |
Family
ID=22625557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95906146T DK0735863T3 (da) | 1993-12-22 | 1994-12-22 | Præparat indeholdende bromocriptin med accelereret frigørelse |
Country Status (15)
Country | Link |
---|---|
US (1) | US5679685A (da) |
EP (2) | EP0735863B1 (da) |
JP (1) | JP3150343B2 (da) |
AT (1) | ATE227566T1 (da) |
AU (1) | AU1447595A (da) |
CA (1) | CA2179540C (da) |
DE (1) | DE69431729T2 (da) |
DK (1) | DK0735863T3 (da) |
ES (1) | ES2186711T3 (da) |
IL (1) | IL112106A0 (da) |
MX (1) | MX9500243A (da) |
PT (1) | PT735863E (da) |
TW (1) | TW389696B (da) |
WO (1) | WO1995017170A1 (da) |
ZA (1) | ZA9410263B (da) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030026835A1 (en) * | 1999-02-15 | 2003-02-06 | Sumitomo Pharmaceuticals Company Limited | Tablets disintegrating rapidly in the oral cavity |
DE10053397A1 (de) * | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
US20070243240A9 (en) * | 2000-08-24 | 2007-10-18 | Fred Windt-Hanke | Transdermal therapeutic system |
DE10043321B4 (de) * | 2000-08-24 | 2005-07-28 | Neurobiotec Gmbh | Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung |
DE10064453A1 (de) * | 2000-12-16 | 2002-07-04 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
FR2834889B1 (fr) * | 2002-01-18 | 2004-04-02 | Roquette Freres | Forme pharmaceutique solide orodispersible |
US20030228370A1 (en) * | 2002-06-11 | 2003-12-11 | Michel Serpelloni | Orodispersible solid pharmaceutical form |
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
US9655865B2 (en) | 2002-07-29 | 2017-05-23 | Veroscience, Llc | Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes |
US20040220190A1 (en) * | 2002-07-29 | 2004-11-04 | Cincotta Anthony H. | Methods of treating metabolic syndrome using dopamine receptor agonists |
US8821915B2 (en) | 2002-08-09 | 2014-09-02 | Veroscience, Llc | Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
DE60313745T2 (de) * | 2003-05-19 | 2008-01-24 | Euro-Celtique S.A. | Verwendung von Seifen wie Magnesium Stearate zur Beschleunigung der Freisetzung von Wirkstoffen |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US20100035886A1 (en) | 2007-06-21 | 2010-02-11 | Veroscience, Llc | Parenteral formulations of dopamine agonists |
US8741918B2 (en) * | 2007-06-21 | 2014-06-03 | Veroscience Llc | Parenteral formulations of dopamine agonists |
EP3524248A1 (en) | 2007-06-21 | 2019-08-14 | VeroScience LLC | Method of treating metabolic disorders and depression with dopamine receptor agonists |
US9352025B2 (en) | 2009-06-05 | 2016-05-31 | Veroscience Llc | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders |
EP2456427B1 (en) | 2009-07-22 | 2015-03-04 | Grünenthal GmbH | Hot-melt extruded controlled release dosage form |
AR077420A1 (es) | 2009-07-22 | 2011-08-24 | Gruenenthal Gmbh | Forma de dosificacion resistente a la manipulacion para opiaceos sensibles a la oxidacion |
ES2486791T3 (es) | 2010-09-02 | 2014-08-19 | Grünenthal GmbH | Forma de dosificación resistente a la manipulación que comprende una sal inorgánica |
RS56527B1 (sr) | 2011-07-29 | 2018-02-28 | Gruenenthal Gmbh | Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu |
LT2736495T (lt) | 2011-07-29 | 2017-11-10 | Grünenthal GmbH | Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu |
EP2838512B1 (en) | 2012-04-18 | 2018-08-22 | Grünenthal GmbH | Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
US8431155B1 (en) | 2012-04-30 | 2013-04-30 | Veroscience Llc | Bromocriptine formulations |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
HUE051406T2 (hu) | 2012-11-14 | 2021-03-01 | Grace W R & Co | Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók |
MX371432B (es) | 2013-05-29 | 2020-01-30 | Gruenenthal Gmbh | Forma de dosificacion resistente al uso indebido que contiene una o mas particulas. |
EP3073994A1 (en) | 2013-11-26 | 2016-10-05 | Grünenthal GmbH | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
EP3142646A1 (en) | 2014-05-12 | 2017-03-22 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
AU2015266117A1 (en) | 2014-05-26 | 2016-11-24 | Grunenthal Gmbh | Multiparticles safeguarded against ethanolic dose-dumping |
EA035434B1 (ru) | 2015-04-24 | 2020-06-15 | Грюненталь Гмбх | Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями |
JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
ES2897475T3 (es) | 2016-04-20 | 2022-03-01 | Veroscience Llc | Composición y método para el tratamiento de trastornos metabólicos |
EP4233913A3 (en) | 2017-10-18 | 2023-10-18 | VeroScience LLC | Improved bromocriptine formulations |
CA3149877A1 (en) | 2019-09-23 | 2021-04-01 | Anthony H. Cincotta | Method for inducing tumor regression |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3074847A (en) * | 1960-04-27 | 1963-01-22 | Frank L Bigsby | Appetite control composition |
CH507249A (de) * | 1968-05-31 | 1971-05-15 | Sandoz Ag | Verfahren zur Herstellung von 2-Brom-a-ergokryptin |
CA990287A (en) * | 1972-09-26 | 1976-06-01 | Sandoz Patents Limited | 13-bromo-lysergic acid compounds |
US3849562A (en) * | 1973-03-15 | 1974-11-19 | Sandoz Ltd | Method of treating nephrosis |
US3922347A (en) * | 1974-12-19 | 1975-11-25 | Lilly Co Eli | Method of inhibiting prolactin secretion with 8-acylaminoergolenes |
US4054660A (en) * | 1975-04-14 | 1977-10-18 | Eli Lilly And Company | Method of inhibiting prolactin |
US4151283A (en) * | 1977-02-17 | 1979-04-24 | Societa' Farmaceutici Italia S.P.A. | 6-Methyl-and 1,6-dimethyl-8β-carbobenzyloxy-aminomethyl-10α-ergoline as inhibitors of prolactin secretion |
YU216177A (en) * | 1977-09-09 | 1984-02-29 | Rudolf Rucman | Process for preparing 2-bromo ergosine |
IT1157365B (it) * | 1977-10-24 | 1987-02-11 | Sandoz Ag | Medicamenti per trattare l'obesita' o ridurre il peso del corpo |
BE890369A (fr) * | 1980-09-18 | 1982-03-16 | Sandoz Sa | Nouveaux medicaments a base d'inhibiteurs de la secretion de la prolactine pour le traitement de l'arteriosclerose |
DE3216870A1 (de) * | 1982-05-03 | 1983-11-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Pharmazeutische zubereitungen mit zytostatischer wirkung |
GB2154874B (en) * | 1984-02-29 | 1987-11-04 | Sandoz Ltd | Bromoscriptine compositions |
US4935429A (en) * | 1985-10-25 | 1990-06-19 | Dackis Charles A | Method of treating psychostimulant addiction |
US4783469A (en) * | 1986-03-07 | 1988-11-08 | Meier Albert H | Method of inhibiting body fat stores |
US4659715A (en) * | 1986-03-07 | 1987-04-21 | Louisiana State University And Agricultural And Mechanical College | Method of inhibiting body fat stores |
US4749709A (en) * | 1986-03-07 | 1988-06-07 | Louisiana State University And Agricultural And Mechanical College | Method of inhibiting body fat stores |
DE3722383A1 (de) * | 1986-07-14 | 1988-01-28 | Sandoz Ag | Neue verwendung von bromocriptin |
DE3868866D1 (de) * | 1987-11-20 | 1992-04-09 | Erba Carlo Spa | Ergolinderivate mit antiparkinsonwirkung. |
US5073555A (en) * | 1988-04-04 | 1991-12-17 | George D. McAdory | Medicaments intended for combined use in the improvement of lymphocyte function to lower cholesterol levels |
US5344832A (en) * | 1990-01-10 | 1994-09-06 | The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College | Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
US5006526A (en) * | 1988-10-17 | 1991-04-09 | Louisiana State University | Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis |
US5073374A (en) * | 1988-11-30 | 1991-12-17 | Schering Corporation | Fast dissolving buccal tablet |
IT1235053B (it) * | 1989-04-07 | 1992-06-17 | Poli Ind Chimica Spa | Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti. |
DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
US5229131A (en) * | 1990-02-05 | 1993-07-20 | University Of Michigan | Pulsatile drug delivery system |
US5221536A (en) * | 1990-05-07 | 1993-06-22 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5190763A (en) * | 1990-05-07 | 1993-03-02 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5128145A (en) * | 1990-06-13 | 1992-07-07 | Alza Corporation | Dosage form for Parkinson's disease, spasticity and muscle spasms |
CZ282909B6 (cs) * | 1991-12-23 | 1997-11-12 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Použití agonisty dopaminu a stimulátoru prolaktinu pro přípravu farmaceutického přípravku a tento farmaceutický přípravek |
FR2690340B1 (fr) * | 1992-04-24 | 1995-02-24 | Scr Newmed | Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant. |
-
1994
- 1994-12-21 IL IL11210694A patent/IL112106A0/xx not_active IP Right Cessation
- 1994-12-22 AU AU14475/95A patent/AU1447595A/en not_active Abandoned
- 1994-12-22 PT PT95906146T patent/PT735863E/pt unknown
- 1994-12-22 EP EP95906146A patent/EP0735863B1/en not_active Expired - Lifetime
- 1994-12-22 EP EP02018888A patent/EP1258245A3/en not_active Withdrawn
- 1994-12-22 WO PCT/US1994/014994 patent/WO1995017170A1/en active IP Right Grant
- 1994-12-22 ZA ZA9410263A patent/ZA9410263B/xx unknown
- 1994-12-22 DE DE69431729T patent/DE69431729T2/de not_active Expired - Lifetime
- 1994-12-22 AT AT95906146T patent/ATE227566T1/de active
- 1994-12-22 ES ES95906146T patent/ES2186711T3/es not_active Expired - Lifetime
- 1994-12-22 DK DK95906146T patent/DK0735863T3/da active
- 1994-12-22 CA CA002179540A patent/CA2179540C/en not_active Expired - Fee Related
- 1994-12-22 JP JP51764495A patent/JP3150343B2/ja not_active Expired - Fee Related
-
1995
- 1995-01-02 MX MX9500243A patent/MX9500243A/es unknown
- 1995-03-04 TW TW084102083A patent/TW389696B/zh active
- 1995-06-02 US US08/459,021 patent/US5679685A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ZA9410263B (en) | 1995-08-29 |
WO1995017170A1 (en) | 1995-06-29 |
JP3150343B2 (ja) | 2001-03-26 |
TW389696B (en) | 2000-05-11 |
ATE227566T1 (de) | 2002-11-15 |
ES2186711T3 (es) | 2003-05-16 |
EP0735863A4 (en) | 1997-08-20 |
CA2179540A1 (en) | 1995-06-29 |
AU1447595A (en) | 1995-07-10 |
EP0735863A1 (en) | 1996-10-09 |
US5679685A (en) | 1997-10-21 |
MX9500243A (es) | 1997-02-28 |
IL112106A0 (en) | 1995-03-15 |
CA2179540C (en) | 2002-05-14 |
JPH09510955A (ja) | 1997-11-04 |
DE69431729T2 (de) | 2003-07-17 |
EP1258245A3 (en) | 2003-01-02 |
EP1258245A2 (en) | 2002-11-20 |
DE69431729D1 (de) | 2002-12-19 |
EP0735863B1 (en) | 2002-11-13 |
PT735863E (pt) | 2003-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0735863T3 (da) | Præparat indeholdende bromocriptin med accelereret frigørelse | |
AU6060896A (en) | Oral 1alpha-hydroxyprevitamin D | |
CA2111002A1 (en) | Non-Chlorofluorocarbon Aerosol Formulations | |
DK568687A (da) | Hydromorphonpraeparat med reguleret afgivelse | |
BG104620A (en) | Oral pharmaceutical extended release dosage form | |
GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
IL100502A0 (en) | Pharmaceutical compositions containing 1,3-oxathiolane nucleoside analogues | |
HU9302493D0 (en) | Application of 5-fluorine-2'-desoxi-3'-thia-cytidine for treatment of hepatitis b | |
AU2553992A (en) | Bone-growth-stimulating composition | |
DE69105040T2 (de) | Arzneimittel gegen Impotenz. | |
ZA898667B (en) | Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment | |
NO962752L (no) | Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose | |
GR3025518T3 (en) | Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus | |
IL98199A0 (en) | Pharmaceutical compositions containing a derivative of substituted-l-valyl-l-prolinamide | |
EP0207882A3 (de) | Verwendung von Tergurid zur Herstellung eines Arzneimittels zur Behandlung geriatrischer Beschwerden | |
CY2337B1 (en) | Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 invection. | |
DK0457336T3 (da) | Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat | |
ZA968315B (en) | Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof | |
ITLE920004V0 (it) | Mutandina - pannolino in cotone 100% utile per la prevenzione e cura della displasia dell'anca per i neonati |